Herbert Hurwitz, MD, is currently the Principal Medical Director of Cancer Immunotherapy Development at Genentech, where they focus on drug development in gastrointestinal cancers and oncology biomarker development. Previously, they served as an Associate Professor of Medicine with Tenure at Duke University Medical Center from 2004 to 2013 and held an Associate position in Oncology at The Johns Hopkins University School of Medicine in 1996. Herbert earned an M.D. from Jefferson Medical College and completed their clinical fellowship in oncology at The Johns Hopkins University School of Medicine, where they also obtained a Master's in Clinical Investigation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices